JANE TODD CRAWFORD HOSPITAL — History
CCN 181325 | 3-year financial timeline | COVID resilience: 23/100
🛡️ Public data only — no PHI permitted on this instance.
$36M
Latest Revenue (FY2022)
-7.5%
Revenue CAGR (3yr)
20.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $42M | $11M | $36M | +225.6% | -7.5% |
| Operating Expenses | $22M | $25M | $29M | +14.8% | +14.9% |
| Operating Margin | 48.2% | -100.0% | 20.0% | +120.0% | -35.5% |
| Net Income | $20M | $-14M | $7M | +151.5% | -40.3% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 6,114 | 6,183 | 6,898 | +11.6% | +6.2% |
| Medicare Day % | 16% | 12% | 17% | +40.1% | +2.7% |
| Medicaid Day % | 77% | 82% | 77% | -5.8% | +0.2% |
COVID Impact & Recovery
Resilience Score: 23/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -14.4% ($42M → $36M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-7.5%
This Hospital
+7.6%
State Avg
Latest Margin
20.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $33M | 6.0% |
| FY2024 (proj) | $30M | -8.1% |
| FY2025 (proj) | $27M | -22.1% |